Macrophage lineages in heart valve development and disease

Cardiovasc Res. 2021 Feb 22;117(3):663-673. doi: 10.1093/cvr/cvaa062.

Abstract

Heterogeneous macrophage lineages are present in the aortic and mitral valves of the heart during development and disease. These populations include resident macrophages of embryonic origins and recruited monocyte-derived macrophages prevalent in disease. Soon after birth, macrophages from haematopoietic lineages are recruited to the heart valves, and bone marrow transplantation studies in mice demonstrate that haematopoietic-derived macrophages continue to invest adult valves. During myxomatous heart valve disease, monocyte-derived macrophages are recruited to the heart valves and they contribute to valve degeneration in a mouse model of Marfan syndrome. Here, we review recent studies of macrophage lineages in heart valve development and disease with discussion of clinical significance and therapeutic applications.

Keywords: Heart valve; Macrophage; Myxomatous valve disease; Valve development.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Cardiovascular Agents / therapeutic use
  • Cell Lineage*
  • Gene Expression Regulation, Developmental
  • Heart Valve Diseases / drug therapy
  • Heart Valve Diseases / genetics
  • Heart Valve Diseases / metabolism
  • Heart Valve Diseases / pathology*
  • Heart Valves / drug effects
  • Heart Valves / metabolism
  • Heart Valves / pathology*
  • Humans
  • Macrophages / drug effects
  • Macrophages / metabolism
  • Macrophages / pathology*
  • Molecular Targeted Therapy
  • Morphogenesis
  • Phenotype
  • Receptors, CCR2 / antagonists & inhibitors
  • Receptors, CCR2 / metabolism

Substances

  • Cardiovascular Agents
  • Receptors, CCR2